Skip to Main Content

Paper Details

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
J Thorac Oncol
51
2020
LS-SCLC, Pembrolizumab, Pneumonitis, SCLC, a, esophagitis, etoposide, neuroendocrine tumors, neutropenia, patients, pembrolizumab, platin, respiratory failure, tumor
Author NameAffiliation
Kenneth R HessThe University of Texas MD Anderson Cancer Center
Kenneth R HessThe University of Texas MD Anderson Cancer Center
Jianjun ZhangThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2